Supporting Drug Development in ALS Through the Use of Digital Health Technologies
Time: 2:00 pm
day: Day One Track B PM
Details:
- Discussing ALS signs and symptom domain assessments with Digital Health Technologies (DHTs)
- Understanding the role DHTs can play in drug development tools (including COAs, biomarkers, and models/methodologies)
- Discussing the potential of DHTs to support quicker and more consistent diagnoses, and progression, and enabling targeted interventions at earlier stages through patient selection
